Navigation Links
Brachytherapy For Breast Cancer Can Be Risky

A new study published in the June 2006 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society //for Therapeutic Radiology and Oncology, says that doctors in New England have found that patients receiving partial radiation for the breast in order to combat breast cancer have the risk of developing a seroma.

A seroma is retention of fluid in the breast, which can complicate matters since it requires aspiration. The study followed 38 women who had the procedure after undergoing lumpectomy surgery to remove the cancer. After the surgery, a balloon brachytherapy method is used to place a balloon in the space occupied by the tumor.

Radiation Oncologists then deliver high doses of radiation locally in order to kill off any remaining cancer cells. In the current study 76.3 percent of them developed seroma in their breast and 68.4 percent of the patients had it for over 6 months.

'Seroma is not infrequent after surgery, but it typically resolves itself within a few weeks. However, with these patients, the seroma didn’t resolve,' said Suzanne B. Evans, M.D., M.P.H., lead author of the study and a radiation oncology resident at Tufts-New England Medical Center. 'We look forward to other studies in which the device is placed post-operatively to determine whether this lowers the rate of seroma formation.'


'"/>




Page: 1

Related medicine news :

1. Brachytherapy for breast cancer
2. Brachytherapy Shows Promise for Cancer Treatment
3. Prostate Brachytherapy Causes Fewer Side Effects Than Surgery
4. Consensus on "Combination Therapy" for Breast Cancer
5. Breast cancer treatment to be determined by gene test
6. Breast Feeding prevents obesity later on in life
7. Breast milk is essential
8. Breast Cancer Surgery Causes Psychological problems
9. Breast cancer evidence
10. Letrozole Beats Tamoxifen in Breast Cancer Therapy
11. Breast screening among diabetic women
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... ... April 29, 2017 , ... Phytomer USA is pleased to introduce ... Account Manager, Smith’s role is to provide excellent customer service, support, training and ... Phytomer Group. Smith comes to Phytomer with a wealth of industry experience including roles ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today ... outlook as “stable.” At the same time, the ratings agency cautioned that the company’s ... below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management Association (RBMA) ... The annual board election process has been in place since the RBMA was founded ... Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the ...
(Date:4/28/2017)... Linda, Ca (PRWEB) , ... April 28, 2017 ... ... with cardiac or hERG liability could substantially improve drug safety and minimize the ... be provided for validating ion channel inhibition using cell lines and for cardiac ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... 19, 2017  New research provides evidence that an old ... to a study released today that will be presented at ... in Boston , April 22 to 28, ... of Parkinson,s disease, the oral drug levodopa has long been ... But as the disease progresses, the effects of the medication ...
Breaking Medicine Technology: